Positive inotropic effect of interleukin-2. Role of phospholipases and protein kinase C

Int J Immunopharmacol. 1991;13(5):509-15. doi: 10.1016/0192-0561(91)90070-n.

Abstract

Recently, we have shown that soluble factors released by human lymphocytes after lectin stimulation could increase the contractile tension of rat atria "in vitro" and that interleukin-2 (IL-2) could be part of this reaction. The effect of IL-2 was potentiated by the Ca2+ ionophore A23187 or free arachidonic acid (AA). In this study we demonstrate that the action of IL-2 can be prevented by pre-incubation of the heart tissue with monoclonal anti-IL-2 receptor (anti-p55), suggesting that binding to the IL-2 receptor is necessary for the induction of the biologic effect. In the presence of A23187 or AA, the effect of the synthetic diacylglyceride oleoyl-acetyl-glycerol (OAG) was similar to that of IL-2. Elimination of phospholipase C activity by pre-incubation of the atria with 2-nitro-carboxyphenyl,N,N'-diphenylcarbamate (NCDC) abrogated the effects of IL-2 in the presence of A23187 or AA, but was ineffective when OAG + A23187 or OAG + AA was used. Inhibition of atrial phospholipase A2 activity with p-bromo-phenacylbromide (BPB) blocked the response of atria to either IL-2 + A23187 or OAG + A23187 but was not effective when AA was used as second signal (IL-2 + AA or OAG + AA). Both the OAG and the IL-2 positive inotropic effects could be prevented by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methyl-piperazine (H7) but were poorly inhibited by N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA1004), an inhibitor of the cyclic nucleotide-dependent protein kinases.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acids / metabolism
  • Heart Atria / drug effects
  • Interleukin-2 / pharmacology*
  • Lipoxygenase / metabolism
  • Myocardial Contraction / drug effects*
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / physiology*
  • Phospholipases A2
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Protein Kinase Inhibitors
  • Protein Kinases / physiology*
  • Rats
  • Receptors, Interleukin-2 / metabolism
  • Second Messenger Systems / drug effects
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / physiology*

Substances

  • Arachidonic Acids
  • Interleukin-2
  • Protein Kinase Inhibitors
  • Receptors, Interleukin-2
  • Lipoxygenase
  • Prostaglandin-Endoperoxide Synthases
  • Protein Kinases
  • Phospholipases A
  • Phospholipases A2
  • Type C Phospholipases